Atea Pharmaceuticals Management
How experienced are the management team and are they aligned to shareholders interests?
2.4yrs
Average management tenure
CEO
Jean-Pierre Sommadossi (66 yo)
10.5yrs
Tenure
US$34,104,892
Compensation
Dr. Jean-Pierre Sommadossi, Ph D., is a Founder of Atea Pharmaceuticals, Inc. and has been its Chairman, Director, Chief Executive Officer and President since July 2012 and had been its Treasurer. Dr. Somm...
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | US$36m |
| Jun 30 2022 | n/a | n/a | US$16m |
| Mar 31 2022 | n/a | n/a | US$48m |
| Dec 31 2021 | US$34m | US$650k | US$121m |
| Sep 30 2021 | n/a | n/a | US$25m |
| Jun 30 2021 | n/a | n/a | US$35m |
| Mar 31 2021 | n/a | n/a | US$24m |
| Dec 31 2020 | US$3m | US$437k | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$36m |
| Jun 30 2020 | n/a | n/a | -US$22m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$811k | US$400k | -US$14m |
Compensation vs Market: Jean-Pierre's total compensation ($USD34.10M) is above average for companies of similar size in the US market ($USD2.50M).
Compensation vs Earnings: Jean-Pierre's compensation has increased by more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 10.5yrs | US$34.10m | 7.11% $ 27.0m | |
| CFO, Executive VP of Legal & Secretary | 9.08yrs | US$8.36m | 0.76% $ 2.9m | |
| Chief Commercial Officer | 4.25yrs | US$6.60m | 0.099% $ 375.4k | |
| Chief Development Officer | 2.42yrs | US$9.01m | 0% $ 0 | |
| Chief Medical Officer | 2.42yrs | US$8.14m | 0% $ 0 | |
| Executive VP of Finance & Chief Accounting Officer | no data | no data | no data | |
| Senior Vice President of Investor Relations & Corporate Communications | 2yrs | no data | no data | |
| Vice President of Marketing | 1yr | no data | no data | |
| Executive Vice President of Chemistry | no data | no data | no data | |
| Executive Vice President of Early Stage Development | no data | no data | no data | |
| Senior Vice President of Clinical Sciences | 3yrs | no data | no data | |
| Executive Vice President of Regulatory Affairs | 2yrs | no data | no data |
2.4yrs
Average Tenure
59yo
Average Age
Experienced Management: AVIR's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 10.5yrs | US$34.10m | 7.11% $ 27.0m | |
| Independent Director | 2.25yrs | US$602.11k | 0% $ 0 | |
| Independent Director | 8.33yrs | US$592.04k | 0.060% $ 227.5k | |
| Lead Independent Director | 3.33yrs | US$622.67k | 0.93% $ 3.5m | |
| Independent Director | 8.17yrs | US$593.91k | 0.060% $ 227.5k | |
| Independent Director | 2.42yrs | US$595.21k | 0.028% $ 106.0k | |
| Independent Director | 1.67yrs | US$971.45k | 0% $ 0 |
3.3yrs
Average Tenure
62yo
Average Age
Experienced Board: AVIR's board of directors are considered experienced (3.3 years average tenure).